Metropolitan Life Insurance Company (MetLife)’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,098
Closed -$16.4K 309
2024
Q1
$16.4K Sell
1,098
-388
-26% -$6.39K ﹤0.01% 1950
2023
Q4
$21.6K Hold
1,486
﹤0.01% 1888
2023
Q3
$20.4K Buy
1,486
+383
+35% +$6.91K ﹤0.01% 1888
2023
Q2
$24.2K Buy
+1,103
New +$34.5K ﹤0.01% 1826

Other funds holding BMEA

Metropolitan Life Insurance Company (MetLife)'s BMEA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Biomea Fusion (BMEA) in Q2 2024, closing a stake of 1,098 shares — an estimated $16.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BMEA in Q2 2023 and held it in 4 quarters. The position peaked at $24.2K in Q2 2023. 107 funds tracked by Wall St. Rank hold BMEA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Biomea Fusion position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,098 Biomea Fusion shares in Q2 2024, an estimated $16.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Biomea Fusion in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Biomea Fusion position peaked at $24.2K in Q2 2023.
  • 107 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.